Pseudo–peptides in Drug Discovery

  • ID: 2183683
  • Book
  • 256 Pages
  • John Wiley and Sons Ltd
1 of 4
Peptides are among the most versatile bioactive molecules, yet the do not make good drugs, because they are quickly degraded or modified in the body.

Thus, drug discovery has turned to the novel field of peptidomimetics, i. e. to design non–peptide compounds mimicking the pharmacophore and thus the activity of the original peptide. These novel compounds open up new perspectives in drug design by providing an entire range of highly specific pharmaceuticals that have a high bioavailability.

In particular, the following classes of pseudo–peptides are introduced and examined with regard to their chemical properties, pharmacological activity, as well as practical aspects of synthesis:

∗ Oligo–glycines

∗ Beta–peptides

∗ Gamma–peptides

∗ Pyrrole–imidazole polyamides

∗ DNA–like peptide nucleic acids

∗ Alpha–helical peptide nucleic acids

∗ DNA–cleaving pseudo–peptides

The first work drawing together knowledge gained on different types of pseudo–peptides with drug properties, this book is an essential resource for drug developers and bioorganic chemists working with those compounds.

Note: Product cover images may vary from those shown
2 of 4
Versatile oligo–glycines: The many roles of peptoids in drug discovery

Beta–peptides, gamma–peptides and isosteric backbones: New scaffolds with controlled shapes

Regulation of gene expression with pyrrole–imidazole polyamides

Peptide nucleic acid: A pseudo–peptide with DNA–like properties

Alpha–helical peptide nucleic acids

DNA–cleaving pseudo–peptides

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Peter E. Nielsen
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll